| |||||||||||||||
|
|
|
Today's Headline TG2 Identified as Potential Target in Chemo-Resistant Ovarian Cancer - University of Texas M. D. Anderson Cancer Center have found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates. When researchers targeted and silenced TG2 in animal models, cancer progression was reversed, suggesting the protein may also provide a novel therapeutic approach for late-stage ovarian cancer. (Read More) Other News  Featured Sites July: Nutrition and Healthy Living OncoLog Center for Cancer Epigenetics Symposia on Cancer Research Research and Clinical Achievements
|
